Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Autonomic Nervous System Activity Records

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Autonomic Nervous System Activity Records1
  • Adapted Physical Activity1
  • Pediatric Cancer Young Adult Survivors1
  • Unique Medical Visit Of The Study1

Active Sponsors

  • Centre Hospitalier Universitaire de Saint Etienne4
  • National Cancer Institute, France1

Top Investigators

Related Conditions

  • Complications4
  • Cancer3
  • Pediatric Cancer1
  • Autonomic Nervous System1

Activity Timeline